114 related articles for article (PubMed ID: 22161641)
1. Influence of solvent on the morphology and subsequent comminution of ibuprofen crystals by air jet milling.
Shariare MH; Blagden N; de Matas M; Leusen FJ; York P
J Pharm Sci; 2012 Mar; 101(3):1108-19. PubMed ID: 22161641
[TBL] [Abstract][Full Text] [Related]
2. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.
Shariare MH; de Matas M; York P
Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128
[TBL] [Abstract][Full Text] [Related]
3. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
4. Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.
Han X; Jallo L; To D; Ghoroi C; Davé R
J Pharm Sci; 2013 Jul; 102(7):2282-96. PubMed ID: 23658057
[TBL] [Abstract][Full Text] [Related]
5. Engineering of acetaminophen particle attributes using a wet milling crystallisation platform.
Ahmed B; Brown CJ; McGlone T; Bowering DL; Sefcik J; Florence AJ
Int J Pharm; 2019 Jan; 554():201-211. PubMed ID: 30391338
[TBL] [Abstract][Full Text] [Related]
6. Properties of ibuprofen crystallized under various conditions: a comparative study.
Rasenack N; Müller BW
Drug Dev Ind Pharm; 2002 Oct; 28(9):1077-89. PubMed ID: 12455467
[TBL] [Abstract][Full Text] [Related]
7. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
[TBL] [Abstract][Full Text] [Related]
8. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.
Ruether F; Sadowski G
J Pharm Sci; 2009 Nov; 98(11):4205-15. PubMed ID: 19283772
[TBL] [Abstract][Full Text] [Related]
9. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers.
Kachrimanis K; Nikolakakis I; Malamataris S
J Pharm Sci; 2000 Feb; 89(2):250-9. PubMed ID: 10688754
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Ibuprofen Microparticles by Antisolvent Precipitation Crystallization Technique: Characterization, Formulation, and In Vitro Performance.
Afrose A; White ET; Howes T; George G; Rashid A; Rintoul L; Islam N
J Pharm Sci; 2018 Dec; 107(12):3060-3069. PubMed ID: 30098991
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen crystals with optimized properties.
Rasenack N; Müller BW
Int J Pharm; 2002 Oct; 245(1-2):9-24. PubMed ID: 12270238
[TBL] [Abstract][Full Text] [Related]
12. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules.
Abioye AO; Kola-Mustapha A; Ruparelia K
Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327
[TBL] [Abstract][Full Text] [Related]
13. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
Int J Pharm; 2012 Jul; 430(1-2):26-33. PubMed ID: 22449413
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS).
Abioye AO; Chi GT; Simone E; Nagy Z
Int J Pharm; 2016 Jul; 509(1-2):264-278. PubMed ID: 27260131
[TBL] [Abstract][Full Text] [Related]
15. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties.
Shen SC; Ng WK; Chia L; Dong YC; Tan RB
J Pharm Sci; 2010 Apr; 99(4):1997-2007. PubMed ID: 19816955
[TBL] [Abstract][Full Text] [Related]
16. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs.
Chu KR; Lee E; Jeong SH; Park ES
Arch Pharm Res; 2012 Jul; 35(7):1187-95. PubMed ID: 22864741
[TBL] [Abstract][Full Text] [Related]
17. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
18. Robust Wet Milling Technique for Producing Micronized Ibuprofen Particles with Improved Solubility and Dissolution.
Sharif S; Muneer S; Wang T; Izake EL; Islam N
AAPS PharmSciTech; 2022 Dec; 24(1):16. PubMed ID: 36522579
[TBL] [Abstract][Full Text] [Related]
19. Investigation of solid-state NMR line widths of ibuprofen in drug formulations.
Barich DH; Davis JM; Schieber LJ; Zell MT; Munson EJ
J Pharm Sci; 2006 Jul; 95(7):1586-94. PubMed ID: 16732561
[TBL] [Abstract][Full Text] [Related]
20. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
